Communicating the benefits and risks of inflammatory bowel disease therapy to patients and families

Picoraro Joseph A.; Rosh Joel R.

首页> 外文期刊>Current opinion in pediatrics >Communicating the benefits and risks of inflammatory bowel disease therapy to patients and families

【24h】

Communicating the benefits and risks of inflammatory bowel disease therapy to patients and families

机译：沟通炎症性肠病治疗对患者和家庭的益处和风险

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose of review

机译：审查的目的

著录项

来源
《Current opinion in pediatrics》 |2017年第5期|共6页
作者
Picoraro Joseph A.; Rosh Joel R.;
展开▼
作者单位

Columbia Univ Med Ctr Div Pediat Gastroenterol Hepatol &

Nutr New York NY USA;

Goryeb Childrens Hosp Div Gastroenterol &

Nutr 100 Madison Ave Morristown NJ 07960 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词
Crohn's disease; inflammatory bowel disease; pediatrics; shared decision-making; ulcerative colitis;

机译：克罗恩病;炎症性肠病;儿科;共同决策;溃疡性结肠炎;

相似文献

外文文献
中文文献
专利

1. Communicating the benefits and risks of inflammatory bowel disease therapy to patients and families [J] . Picoraro Joseph A., Rosh Joel R. Current opinion in pediatrics . 2017,第5期

机译：沟通炎症性肠病治疗对患者和家庭的益处和风险
2. Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: Risks and benefits [J] . Chang Bianca W., Kumar Aryavarta M. S., Koyfman Shlomo A., International journal of colorectal disease. . 2015,第3期

机译：炎症性肠病和大肠癌患者的放射治疗：风险和收益
3. Balancing Benefit vs Risk of Immunosuppressive Therapy for Individual Patients With Inflammatory Bowel Diseases [J] . Beaugerie Laurent, Kirchgesner Julien Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2019,第3期

机译：平衡益处与炎症性肠病患者免疫抑制治疗的风险
4. Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases [C] . J.-F. COLOMBEL, M. TORUNE Falk Symposium . 2007

机译：炎症性肠病患者的发病率增加了与免疫调节治疗有关的发病危险
5. Oxidation Status as a Predictor of Disease Activity and Response to Therapy in Pediatric Patients with Inflammatory Bowel Disease [D] . Ajithkumar, Aravindh K. 2020

机译：氧化地位作为疾病活动的预测因素，对炎症性肠病儿科患者的疗法响应
6. Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease [O] . Parambir S. Dulai, Corey A. Siegel, Marla C. Dubinsky -1

机译：平衡和交流小儿炎症性肠病中生物制剂的风险和益处
7. Patient Understanding of the Risks and Benefits of Biologic Therapies in Inflammatory Bowel Disease [O] . Bibiana Martinez, Francis Dailey, Christopher V. Almario, 2017

机译：患者了解炎症性肠病生物疗法的风险和益处

Communicating the benefits and risks of inflammatory bowel disease therapy to patients and families

摘要

著录项

相似文献

相关主题

期刊订阅